WO1999055670A3 - Productos de naturaleza de imidazol y derivados - Google Patents

Productos de naturaleza de imidazol y derivados Download PDF

Info

Publication number
WO1999055670A3
WO1999055670A3 PCT/ES1999/000096 ES9900096W WO9955670A3 WO 1999055670 A3 WO1999055670 A3 WO 1999055670A3 ES 9900096 W ES9900096 W ES 9900096W WO 9955670 A3 WO9955670 A3 WO 9955670A3
Authority
WO
WIPO (PCT)
Prior art keywords
imidazol
derivatives
products
imidazols
spectra
Prior art date
Application number
PCT/ES1999/000096
Other languages
English (en)
French (fr)
Other versions
WO1999055670A2 (es
Inventor
Garcia Paloma Ballesteros
Gonzalez Ma Soledad Gil
Partida Paula Zaderenko
Garcia-Esteller Sebasti Cerdan
Perez Jose Alvarez
Robert J Gillies
Raghumand Natarajn
Sluis Robert Van
Zaver Bhujwala
Original Assignee
Consejo Superior Investigacion
Univ Madrid Nac Educacion
Univ Arizona
Hopkins J School Of Medicine
Garcia Paloma Ballesteros
Gonzalez Ma Soledad Gil
Partida Paula Zaderenko
Cerdan Garcia Esteller Sebasti
Perez Jose Alvarez
Robert J Gillies
Raghumand Natarajn
Sluis Robert Van
Zaver Bhujwala
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES009800801A external-priority patent/ES2144367B1/es
Application filed by Consejo Superior Investigacion, Univ Madrid Nac Educacion, Univ Arizona, Hopkins J School Of Medicine, Garcia Paloma Ballesteros, Gonzalez Ma Soledad Gil, Partida Paula Zaderenko, Cerdan Garcia Esteller Sebasti, Perez Jose Alvarez, Robert J Gillies, Raghumand Natarajn, Sluis Robert Van, Zaver Bhujwala filed Critical Consejo Superior Investigacion
Priority to AU31482/99A priority Critical patent/AU3148299A/en
Publication of WO1999055670A2 publication Critical patent/WO1999055670A2/es
Publication of WO1999055670A3 publication Critical patent/WO1999055670A3/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Productos de naturaleza de imidazol, imidazoles sustituidos, derivados de ésteres imidazol-1-yl- y derivados de ácidos imidazol-1-alcanoicos. Los imidazoles y derivados se utilizan como indicadores extrínsecos en la obtención de imágenes y espectros de RMN.
PCT/ES1999/000096 1998-04-16 1999-04-15 Productos de naturaleza de imidazol y derivados WO1999055670A2 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU31482/99A AU3148299A (en) 1998-04-16 1999-04-15 Imidazol-like products and derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP9800801 1998-04-16
ES009800801A ES2144367B1 (es) 1997-03-06 1998-04-16 Productos de naturaleza de imidazol y derivados.

Publications (2)

Publication Number Publication Date
WO1999055670A2 WO1999055670A2 (es) 1999-11-04
WO1999055670A3 true WO1999055670A3 (es) 1999-12-29

Family

ID=8303476

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES1999/000096 WO1999055670A2 (es) 1998-04-16 1999-04-15 Productos de naturaleza de imidazol y derivados

Country Status (2)

Country Link
AU (1) AU3148299A (es)
WO (1) WO1999055670A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025350A3 (en) * 1999-04-21 2009-12-09 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Determining pH by CEDST MRI

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GIL S. ET AL: "Imidazol-l-Ylalkanoate Esters and their Corresponding Acids. A Novel Series of Extrinsic'H NMR Probes for Intracellular ph", BIOORGANIC OF MEDICINAL CHEMISTRY LETTERS, vol. 2, no. 12, 1992, pages 1717 - 1722 *
GIL S. ET AL: "Imidazol-l-Ylalkanoic Acids as Ectrinsic 'H NMR Probes for the Determination of Intracellular pH, Extracellular pH, Extracellular pH and Cell Volume", BIOORGANIC AND MEDICINAL CHEMISTRY, vol. 2, no. 5, 1994, pages 305 - 314 *
LOPEZ P. ET AL: "The Zwitterion Structure of Imidazol-l-Ylacetic Acids in the Solid State and in Solution", JOURNAL OF MOLECULAR STRUCTURE, vol. 377, 1996, pages 105 - 112 *
ZADERENKO P. ET AL: "Synthesis and Regioselective Hydrolisis of 2-Imidazol-l-Ylsuccinic Esters", J. ORG. CHEM., vol. 59, no. 21, 1994, pages 6268 - 6273 *

Also Published As

Publication number Publication date
WO1999055670A2 (es) 1999-11-04
AU3148299A (en) 1999-11-16

Similar Documents

Publication Publication Date Title
AU3734799A (en) 5-demethoxyfumagillol derivatives and processes for preparing the same
AU6099100A (en) Ultra-rugged i.c. sensor and method of making the same
ZA9711560B (en) Propiophenone derivatives and process for preparing the same.
AU3734699A (en) Fumagillol derivatives and processes for preparing the same
HUP0105480A3 (en) Benzofuran derivatives, process for preparation of the same and uses thereof
HK1072729A1 (en) Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
AU2853199A (en) Freeze-dried foods and process for producing the same
AU3335300A (en) Ingredients for expanded foods
EP0895777A3 (en) Compositions based on peroxyacids
AU1454600A (en) Low moisture, stable food products and methods of preparing the same
EP0685504A3 (en) Polyaspartic acid derivatives and process for their preparation.
AU1278100A (en) 2-acylamino-2-deoxy-glucono-1,5-lactones, method for obtaining same, compositions comprising them and uses
ZA99873B (en) Novel dihydroxyhexanoic acid derivatives.
AU3868299A (en) Flavored oil-in-vinegar microemulsion concentrates, method for preparing the same
AU4779500A (en) Creamy ice cream products containing soy-milk and potato as the main components and process for producing the same
AU4045800A (en) Aryl sulfonic acids and derivatives as fsh antagonists
WO1999055670A3 (es) Productos de naturaleza de imidazol y derivados
AU3851899A (en) Novel substituted guanidine derivatives and process for producing the same
AU2001214181A1 (en) Mayonnaise-like foods and process for producing the same
AU2183899A (en) Isoflavane derivatives and immunopotentiating compositions containing the same
AU3708397A (en) Sulfonic ester derivatives, process for preparing the same, and use thereof
ES1039279Y (es) Producto de confiteria.
HUP0004916A3 (en) Process for the preparation of 1,2,3,4-tetrahydroisoquinoline-2,3-dicarboxylic acid anhydride and (s)-n-terc-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide by using thereof
AU1618997A (en) Antioxidant and process for producing the same
AU2001252254A1 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparationthereof and use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA